Related Experiment Video
Updated: Jun 3, 2026
07:31
Preparation of Acute Human Hippocampal Slices for Electrophysiological Recordings
Published on: May 7, 2020
Human clinical trails in antiepileptogenesis
Ram Mani1, John Pollard, Marc A Dichter
1Department of Neurology, University of Pennsylvania, United States.
Neuroscience Letters
|March 29, 2011
Summary
Preventing the development of epilepsy (epileptogenesis) is crucial for patient well-being. This review examines mechanisms, interventions, and past trials, suggesting designs for future successful antiepileptogenesis research.
Area of Science:
- Neuroscience
- Clinical Neurology
- Translational Medicine
Background:
- Epileptogenesis, the process by which epilepsy develops, presents a significant challenge in neurology.
- Preventing epilepsy (antiepileptogenesis) could alleviate lifelong medical and social burdens for patients.
- Despite its importance, human antiepileptogenesis trials have been limited and unsuccessful.
Purpose of the Study:
- To review current understanding of epileptogenesis pathophysiology.
- To discuss potential therapeutic interventions for preventing epilepsy.
- To summarize previous antiepileptogenesis clinical trials and propose optimal trial designs.
Main Methods:
- Literature review of epileptogenesis mechanisms.
- Analysis of existing antiepileptogenesis intervention strategies.
- Critical evaluation of past clinical trial designs and outcomes.
Main Results:
- Identified key pathophysiological pathways implicated in epileptogenesis.
- Highlighted several potential pharmacological and non-pharmacological interventions.
- Summarized the limitations and failures of prior human trials.
Conclusions:
- Successful antiepileptogenesis requires a deeper understanding of underlying mechanisms.
- Future trials need carefully considered designs, potentially targeting specific patient populations or time windows.
- Optimized trial designs are essential for advancing epilepsy prevention strategies.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...